BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kabatas S, Civelek E, Boyalı O, Sezen GB, Ozdemir O, Bahar-Ozdemir Y, Kaplan N, Savrunlu EC, Karaöz E. Safety and efficiency of Wharton’s Jelly-derived mesenchymal stem cell administration in patients with traumatic brain injury: First results of a phase I study. World J Stem Cells 2024; 16(6): 641-655 [PMID: 38948099 DOI: 10.4252/wjsc.v16.i6.641]
URL: https://www.wjgnet.com/1948-0210/full/v16/i6/641.htm
Number Citing Articles
1
Ningcen Li, Wenhui Lu, Limei Tang, Lina Zhu, Weibin Deng, Hang Liu, Changquan Huang, Jingying Jin, Jingjiao Zeng, Shitai Chen, Lianqi Geng, Xiuwu Hu, Liang Zhou. Microglia in Post‐Traumatic Brain Injury (TBI) Cognitive Impairment: From Pathological Changes to Therapeutic ApproachesCNS Neuroscience & Therapeutics 2025; 31(8) doi: 10.1111/cns.70568
2
Muzamil Akhtar, Abdulqadir J Nashwan. Evaluating Wharton’s jelly-derived stem cell therapy in autism: Insights from a case studyWorld Journal of Methodology 2025; 15(2): 100074 doi: 10.5662/wjm.v15.i2.100074
3
Qian Zhou, Wei Shen, Liang Wen. Advances in clinical neurorestorative treatments in brain traumaJournal of Neurorestoratology 2025; 13(3): 100191 doi: 10.1016/j.jnrt.2025.100191
4
P. R. Kamchatnov, O. Yu. Tsarapkina, N. G. Malyukova, A. V. Miretskaya, E. F. Danshina, L. A. Skipetrova, R. A. Cheremin. Treatment of post-traumatic cognitive disorders and asthenia: results of an observational studyNeurology, Neuropsychiatry, Psychosomatics 2024; 16(4): 14 doi: 10.14412/2074-2711-2024-4-14-20